LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.0033333
90.55 27.76 991 6928 0.1430 0.5667
MN20160318_Q01
L18
MCF 10A-H2B-mCherry Dasatinib
0.0033333
90.55 27.76 12441 6928 1.7956 1.1525
MN20160318_Q01
L18
MCF 10A-H2B-mCherry Dasatinib
0.0033333
90.55 27.76 2048 6928 0.2956 0.7162
MN20160318_Q01
M15
MCF 10A-H2B-mCherry Dasatinib
0.0033333
90.55 27.76 11740 6928 1.6944 1.1369
MN20160318_Q01
M15
MCF 10A-H2B-mCherry Dasatinib
0.0033333
92.25 27.76 942 6873 0.1371 0.5577
MN20160318_Q01
L18
MCF 10A-H2B-mCherry Dasatinib
0.0033333
92.25 27.76 12760 6873 1.8565 1.1618
MN20160318_Q01
L18
MCF 10A-H2B-mCherry Dasatinib
0.0033333
92.25 27.76 2151 6873 0.3130 0.7282
MN20160318_Q01
M15
MCF 10A-H2B-mCherry Dasatinib
0.0033333
92.25 27.76 11938 6873 1.7369 1.1438
MN20160318_Q01
M15
MCF 10A-H2B-mCherry Dasatinib
0.0033333
93.96 27.76 883 6849 0.1289 0.5455
MN20160318_Q01
L18
MCF 10A-H2B-mCherry Dasatinib
0.0033333
93.96 27.76 12988 6849 1.8963 1.1677
MN20160318_Q01
L18
MCF 10A-H2B-mCherry Dasatinib
0.0033333
93.96 27.76 1988 6849 0.2903 0.7117
MN20160318_Q01
M15
MCF 10A-H2B-mCherry Dasatinib
0.0033333
93.96 27.76 12235 6849 1.7864 1.1515
MN20160318_Q01
M15
MCF 10A-H2B-mCherry Dasatinib
0.0033333
95.66 27.76 915 6712 0.1363 0.5550
MN20160318_Q01
L18
MCF 10A-H2B-mCherry Dasatinib
0.0033333
95.66 27.76 13302 6712 1.9816 1.1804
MN20160318_Q01
L18
MCF 10A-H2B-mCherry Dasatinib
0.0033333
95.66 27.76 1794 6712 0.2673 0.6930
MN20160318_Q01
M15
MCF 10A-H2B-mCherry Dasatinib
0.0033333
95.66 27.76 12512 6712 1.8639 1.1636
MN20160318_Q01
M15
MCF 10A-H2B-mCherry Dasatinib
0.01
1.95 27.76 1 225 0.0044 -0.6673
MN20160318_Q01
E09
MCF 10A-H2B-mCherry Dasatinib
0.01
1.95 27.76 414 225 1.8388 1.4470
MN20160318_Q01
E09
MCF 10A-H2B-mCherry Dasatinib
0.01
1.95 27.76 1 225 0.0044 -0.6673
MN20160318_Q01
J07
MCF 10A-H2B-mCherry Dasatinib
0.01
1.95 27.76 706 225 3.1358 1.9201
MN20160318_Q01
J07
MCF 10A-H2B-mCherry Dasatinib
0.01
3.66 27.76 1 283 0.0035 -0.6287
MN20160318_Q01
E09
MCF 10A-H2B-mCherry Dasatinib
0.01
3.66 27.76 541 283 1.9054 1.4238
MN20160318_Q01
E09
MCF 10A-H2B-mCherry Dasatinib
0.01
3.66 27.76 1 283 0.0035 -0.6287
MN20160318_Q01
J07
MCF 10A-H2B-mCherry Dasatinib
0.01
3.66 27.76 773 283 2.7225 1.6959
MN20160318_Q01
J07
MCF 10A-H2B-mCherry Dasatinib
0.01
5.36 27.76 1 320 0.0031 -0.6101
MN20160318_Q01
E09